The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GRASPA-AML 2012-01 study (NCT01810705): A multicenter, open, randomized phase 2b trial evaluating ERY001 (L-asparaginase encapsulated in red blood cells) plus low-dose cytarabine vs low-dose cytarabine alone, in treatment of newly diagnosed acute myeloid leukemia (AML) elderly patients, unfit for intensive chemotherapy.
 
Xavier G. Thomas
Honoraria - ERYTECH Pharma
 
Emmanuelle Tavernier Tardy
No Relationships to Disclose
 
Romain Guieze
No Relationships to Disclose
 
Patrice Chevallier
No Relationships to Disclose
 
Jean pierre Marolleau
No Relationships to Disclose
 
Frederique Orsini
No Relationships to Disclose
 
Ian Hitchcock
Employment - Orphan Europe
 
Iman El-Hariry
Consulting or Advisory Role - ERYTECH Pharma